The global Lung Cancer Diagnostic And Screening market was valued at US$ 77 million in 2023 and is anticipated to reach US$ 105.2 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.

Lung Cancer Diagnostic And Screening Market

The Lung Cancer Diagnostic and Screening market is experiencing significant growth and is expected to continue to expand in the coming years. Lung cancer is a major global health concern, and early detection and accurate diagnosis are crucial for improving patient outcomes.One major trend in the Lung Cancer Diagnostic and Screening market is the increasing adoption of advanced imaging technologies for lung cancer detection. Technologies such as computed tomography (CT) scans and positron emission tomography (PET) scans are widely used for screening and diagnosing lung cancer. These imaging techniques provide detailed images of the lungs, allowing healthcare professionals to detect lung nodules or tumors at an early stage.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostic And Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostic And Screening.

Report Scope

The Lung Cancer Diagnostic And Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Cancer Diagnostic And Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Diagnostic And Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Diagnostic And Screening Market Report

Report Metric	Details
Report Name	Lung Cancer Diagnostic And Screening Market
Accounted market size in 2023	US$ 77 million
Forecasted market size in 2030	US$ 105.2 million
CAGR	4.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Instrument Consumables and Accessories
Segment by Application	Hospital Independent Diagnostic Laboratory
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, F.Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, AstraZeneca Plc, Abbott Laboratories, Medtronic Plc, Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, KoninklijikePhilips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics lIncorporated, Agilent Technologies lnc, Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc, Canon MedicalSystems Corporation, Eon Health Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Diagnostic And Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lung Cancer Diagnostic And Screening Market growing?

Ans: The Lung Cancer Diagnostic And Screening Market witnessing a CAGR of 4.6% during the forecast period 2024-2030.

What is the Lung Cancer Diagnostic And Screening Market size in 2030?

Ans: The Lung Cancer Diagnostic And Screening Market size in 2030 will be US$ 105.2 million.

Who are the main players in the Lung Cancer Diagnostic And Screening Market report?

Ans: The main players in the Lung Cancer Diagnostic And Screening Market are Pfizer, F.Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, AstraZeneca Plc, Abbott Laboratories, Medtronic Plc, Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, KoninklijikePhilips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics lIncorporated, Agilent Technologies lnc, Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc, Canon MedicalSystems Corporation, Eon Health Inc

What are the Application segmentation covered in the Lung Cancer Diagnostic And Screening Market report?

Ans: The Applications covered in the Lung Cancer Diagnostic And Screening Market report are Hospital, Independent Diagnostic Laboratory

What are the Type segmentation covered in the Lung Cancer Diagnostic And Screening Market report?

Ans: The Types covered in the Lung Cancer Diagnostic And Screening Market report are Instrument, Consumables and Accessories

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Instrument

1.2.3 Consumables and Accessories

1.3 Market by Application

1.3.1 Global Lung Cancer Diagnostic And Screening Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Independent Diagnostic Laboratory

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Diagnostic And Screening Market Perspective (2019-2030)

2.2 Lung Cancer Diagnostic And Screening Growth Trends by Region

2.2.1 Global Lung Cancer Diagnostic And Screening Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Lung Cancer Diagnostic And Screening Historic Market Size by Region (2019-2024)

2.2.3 Lung Cancer Diagnostic And Screening Forecasted Market Size by Region (2025-2030)

2.3 Lung Cancer Diagnostic And Screening Market Dynamics

2.3.1 Lung Cancer Diagnostic And Screening Industry Trends

2.3.2 Lung Cancer Diagnostic And Screening Market Drivers

2.3.3 Lung Cancer Diagnostic And Screening Market Challenges

2.3.4 Lung Cancer Diagnostic And Screening Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Diagnostic And Screening Players by Revenue

3.1.1 Global Top Lung Cancer Diagnostic And Screening Players by Revenue (2019-2024)

3.1.2 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Players (2019-2024)

3.2 Global Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Lung Cancer Diagnostic And Screening Revenue

3.4 Global Lung Cancer Diagnostic And Screening Market Concentration Ratio

3.4.1 Global Lung Cancer Diagnostic And Screening Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostic And Screening Revenue in 2023

3.5 Lung Cancer Diagnostic And Screening Key Players Head office and Area Served

3.6 Key Players Lung Cancer Diagnostic And Screening Product Solution and Service

3.7 Date of Enter into Lung Cancer Diagnostic And Screening Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Diagnostic And Screening Breakdown Data by Type

4.1 Global Lung Cancer Diagnostic And Screening Historic Market Size by Type (2019-2024)

4.2 Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Type (2025-2030)

5 Lung Cancer Diagnostic And Screening Breakdown Data by Application

5.1 Global Lung Cancer Diagnostic And Screening Historic Market Size by Application (2019-2024)

5.2 Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Lung Cancer Diagnostic And Screening Market Size (2019-2030)

6.2 North America Lung Cancer Diagnostic And Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024)

6.4 North America Lung Cancer Diagnostic And Screening Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Diagnostic And Screening Market Size (2019-2030)

7.2 Europe Lung Cancer Diagnostic And Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024)

7.4 Europe Lung Cancer Diagnostic And Screening Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size (2019-2030)

8.2 Asia-Pacific Lung Cancer Diagnostic And Screening Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024)

8.4 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Diagnostic And Screening Market Size (2019-2030)

9.2 Latin America Lung Cancer Diagnostic And Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024)

9.4 Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size (2019-2030)

10.2 Middle East & Africa Lung Cancer Diagnostic And Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024)

10.4 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Lung Cancer Diagnostic And Screening Introduction

11.1.4 Pfizer Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 F.Hoffmann-La Roche AG

11.2.1 F.Hoffmann-La Roche AG Company Detail

11.2.2 F.Hoffmann-La Roche AG Business Overview

11.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Introduction

11.2.4 F.Hoffmann-La Roche AG Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.2.5 F.Hoffmann-La Roche AG Recent Development

11.3 Bristol-Myers Squibb Company

11.3.1 Bristol-Myers Squibb Company Company Detail

11.3.2 Bristol-Myers Squibb Company Business Overview

11.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Introduction

11.3.4 Bristol-Myers Squibb Company Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.3.5 Bristol-Myers Squibb Company Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Detail

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Introduction

11.4.4 Thermo Fisher Scientific Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 AstraZeneca Plc

11.5.1 AstraZeneca Plc Company Detail

11.5.2 AstraZeneca Plc Business Overview

11.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Introduction

11.5.4 AstraZeneca Plc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.5.5 AstraZeneca Plc Recent Development

11.6 Abbott Laboratories

11.6.1 Abbott Laboratories Company Detail

11.6.2 Abbott Laboratories Business Overview

11.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Introduction

11.6.4 Abbott Laboratories Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.6.5 Abbott Laboratories Recent Development

11.7 Medtronic Plc

11.7.1 Medtronic Plc Company Detail

11.7.2 Medtronic Plc Business Overview

11.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Introduction

11.7.4 Medtronic Plc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.7.5 Medtronic Plc Recent Development

11.8 Danaher Corporation

11.8.1 Danaher Corporation Company Detail

11.8.2 Danaher Corporation Business Overview

11.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Introduction

11.8.4 Danaher Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.8.5 Danaher Corporation Recent Development

11.9 Siemens Healthcare GmbH

11.9.1 Siemens Healthcare GmbH Company Detail

11.9.2 Siemens Healthcare GmbH Business Overview

11.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Introduction

11.9.4 Siemens Healthcare GmbH Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.9.5 Siemens Healthcare GmbH Recent Development

11.10 FUJIFILM Corporation

11.10.1 FUJIFILM Corporation Company Detail

11.10.2 FUJIFILM Corporation Business Overview

11.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Introduction

11.10.4 FUJIFILM Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.10.5 FUJIFILM Corporation Recent Development

11.11 KoninklijikePhilips N.V.

11.11.1 KoninklijikePhilips N.V. Company Detail

11.11.2 KoninklijikePhilips N.V. Business Overview

11.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Introduction

11.11.4 KoninklijikePhilips N.V. Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.11.5 KoninklijikePhilips N.V. Recent Development

11.12 GE Healthcare Bio Sciences AB

11.12.1 GE Healthcare Bio Sciences AB Company Detail

11.12.2 GE Healthcare Bio Sciences AB Business Overview

11.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Introduction

11.12.4 GE Healthcare Bio Sciences AB Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.12.5 GE Healthcare Bio Sciences AB Recent Development

11.13 Quest Diagnostics lIncorporated

11.13.1 Quest Diagnostics lIncorporated Company Detail

11.13.2 Quest Diagnostics lIncorporated Business Overview

11.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Introduction

11.13.4 Quest Diagnostics lIncorporated Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.13.5 Quest Diagnostics lIncorporated Recent Development

11.14 Agilent Technologies lnc

11.14.1 Agilent Technologies lnc Company Detail

11.14.2 Agilent Technologies lnc Business Overview

11.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Introduction

11.14.4 Agilent Technologies lnc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.14.5 Agilent Technologies lnc Recent Development

11.15 Qiagen Inc.

11.15.1 Qiagen Inc. Company Detail

11.15.2 Qiagen Inc. Business Overview

11.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Introduction

11.15.4 Qiagen Inc. Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.15.5 Qiagen Inc. Recent Development

11.16 Myriad Genetic Laboratories Inc.

11.16.1 Myriad Genetic Laboratories Inc. Company Detail

11.16.2 Myriad Genetic Laboratories Inc. Business Overview

11.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Introduction

11.16.4 Myriad Genetic Laboratories Inc. Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.16.5 Myriad Genetic Laboratories Inc. Recent Development

11.17 NeoGenomics Laboratories Inc

11.17.1 NeoGenomics Laboratories Inc Company Detail

11.17.2 NeoGenomics Laboratories Inc Business Overview

11.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Introduction

11.17.4 NeoGenomics Laboratories Inc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.17.5 NeoGenomics Laboratories Inc Recent Development

11.18 Canon MedicalSystems Corporation

11.18.1 Canon MedicalSystems Corporation Company Detail

11.18.2 Canon MedicalSystems Corporation Business Overview

11.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Introduction

11.18.4 Canon MedicalSystems Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.18.5 Canon MedicalSystems Corporation Recent Development

11.19 Eon Health Inc

11.19.1 Eon Health Inc Company Detail

11.19.2 Eon Health Inc Business Overview

11.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Introduction

11.19.4 Eon Health Inc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024)

11.19.5 Eon Health Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

F. Hoffmann-La Roche AG

Bristol Myers Squibb Company

Thermo Fisher Scientific

Siemens Healthcare GmbH

Fujifilm Corporation

Qiagen NV

NeoGenomics Laboratories Inc.

KoninklijikePhilips N.V.

GE Healthcare Bio Sciences AB

Quest Diagnostics lIncorporated

Agilent Technologies lnc

Myriad Genetic Laboratories Inc.

Canon MedicalSystems Corporation

Eon Health Inc

List of Tables

Table 1. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Instrument

Table 3. Key Players of Consumables and Accessories

Table 4. Global Lung Cancer Diagnostic And Screening Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Lung Cancer Diagnostic And Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Lung Cancer Diagnostic And Screening Market Share by Region (2019-2024)

Table 8. Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Lung Cancer Diagnostic And Screening Market Share by Region (2025-2030)

Table 10. Lung Cancer Diagnostic And Screening Market Trends

Table 11. Lung Cancer Diagnostic And Screening Market Drivers

Table 12. Lung Cancer Diagnostic And Screening Market Challenges

Table 13. Lung Cancer Diagnostic And Screening Market Restraints

Table 14. Global Lung Cancer Diagnostic And Screening Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Lung Cancer Diagnostic And Screening Market Share by Players (2019-2024)

Table 16. Global Top Lung Cancer Diagnostic And Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic And Screening as of 2023)

Table 17. Ranking of Global Top Lung Cancer Diagnostic And Screening Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Lung Cancer Diagnostic And Screening Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Lung Cancer Diagnostic And Screening Product Solution and Service

Table 21. Date of Enter into Lung Cancer Diagnostic And Screening Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Lung Cancer Diagnostic And Screening Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Type (2019-2024)

Table 25. Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Type (2025-2030)

Table 27. Global Lung Cancer Diagnostic And Screening Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Application (2019-2024)

Table 29. Global Lung Cancer Diagnostic And Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Application (2025-2030)

Table 31. North America Lung Cancer Diagnostic And Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Lung Cancer Diagnostic And Screening Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Lung Cancer Diagnostic And Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Lung Cancer Diagnostic And Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2025-2030) & (US$ Million)

Table 46. Pfizer Company Detail

Table 47. Pfizer Business Overview

Table 48. Pfizer Lung Cancer Diagnostic And Screening Product

Table 49. Pfizer Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. F.Hoffmann-La Roche AG Company Detail

Table 52. F.Hoffmann-La Roche AG Business Overview

Table 53. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product

Table 54. F.Hoffmann-La Roche AG Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 55. F.Hoffmann-La Roche AG Recent Development

Table 56. Bristol-Myers Squibb Company Company Detail

Table 57. Bristol-Myers Squibb Company Business Overview

Table 58. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product

Table 59. Bristol-Myers Squibb Company Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 60. Bristol-Myers Squibb Company Recent Development

Table 61. Thermo Fisher Scientific Company Detail

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product

Table 64. Thermo Fisher Scientific Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 65. Thermo Fisher Scientific Recent Development

Table 66. AstraZeneca Plc Company Detail

Table 67. AstraZeneca Plc Business Overview

Table 68. AstraZeneca Plc Lung Cancer Diagnostic And Screening Product

Table 69. AstraZeneca Plc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 70. AstraZeneca Plc Recent Development

Table 71. Abbott Laboratories Company Detail

Table 72. Abbott Laboratories Business Overview

Table 73. Abbott Laboratories Lung Cancer Diagnostic And Screening Product

Table 74. Abbott Laboratories Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 75. Abbott Laboratories Recent Development

Table 76. Medtronic Plc Company Detail

Table 77. Medtronic Plc Business Overview

Table 78. Medtronic Plc Lung Cancer Diagnostic And Screening Product

Table 79. Medtronic Plc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 80. Medtronic Plc Recent Development

Table 81. Danaher Corporation Company Detail

Table 82. Danaher Corporation Business Overview

Table 83. Danaher Corporation Lung Cancer Diagnostic And Screening Product

Table 84. Danaher Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 85. Danaher Corporation Recent Development

Table 86. Siemens Healthcare GmbH Company Detail

Table 87. Siemens Healthcare GmbH Business Overview

Table 88. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product

Table 89. Siemens Healthcare GmbH Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 90. Siemens Healthcare GmbH Recent Development

Table 91. FUJIFILM Corporation Company Detail

Table 92. FUJIFILM Corporation Business Overview

Table 93. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product

Table 94. FUJIFILM Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 95. FUJIFILM Corporation Recent Development

Table 96. KoninklijikePhilips N.V. Company Detail

Table 97. KoninklijikePhilips N.V. Business Overview

Table 98. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product

Table 99. KoninklijikePhilips N.V. Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 100. KoninklijikePhilips N.V. Recent Development

Table 101. GE Healthcare Bio Sciences AB Company Detail

Table 102. GE Healthcare Bio Sciences AB Business Overview

Table 103. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product

Table 104. GE Healthcare Bio Sciences AB Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 105. GE Healthcare Bio Sciences AB Recent Development

Table 106. Quest Diagnostics lIncorporated Company Detail

Table 107. Quest Diagnostics lIncorporated Business Overview

Table 108. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product

Table 109. Quest Diagnostics lIncorporated Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 110. Quest Diagnostics lIncorporated Recent Development

Table 111. Agilent Technologies lnc Company Detail

Table 112. Agilent Technologies lnc Business Overview

Table 113. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product

Table 114. Agilent Technologies lnc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 115. Agilent Technologies lnc Recent Development

Table 116. Qiagen Inc. Company Detail

Table 117. Qiagen Inc. Business Overview

Table 118. Qiagen Inc. Lung Cancer Diagnostic And Screening Product

Table 119. Qiagen Inc. Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 120. Qiagen Inc. Recent Development

Table 121. Myriad Genetic Laboratories Inc. Company Detail

Table 122. Myriad Genetic Laboratories Inc. Business Overview

Table 123. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product

Table 124. Myriad Genetic Laboratories Inc. Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 125. Myriad Genetic Laboratories Inc. Recent Development

Table 126. NeoGenomics Laboratories Inc Company Detail

Table 127. NeoGenomics Laboratories Inc Business Overview

Table 128. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product

Table 129. NeoGenomics Laboratories Inc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 130. NeoGenomics Laboratories Inc Recent Development

Table 131. Canon MedicalSystems Corporation Company Detail

Table 132. Canon MedicalSystems Corporation Business Overview

Table 133. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product

Table 134. Canon MedicalSystems Corporation Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 135. Canon MedicalSystems Corporation Recent Development

Table 136. Eon Health Inc Company Detail

Table 137. Eon Health Inc Business Overview

Table 138. Eon Health Inc Lung Cancer Diagnostic And Screening Product

Table 139. Eon Health Inc Revenue in Lung Cancer Diagnostic And Screening Business (2019-2024) & (US$ Million)

Table 140. Eon Health Inc Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Lung Cancer Diagnostic And Screening Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Lung Cancer Diagnostic And Screening Market Share by Type: 2023 VS 2030

Figure 3. Instrument Features

Figure 4. Consumables and Accessories Features

Figure 5. Global Lung Cancer Diagnostic And Screening Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Lung Cancer Diagnostic And Screening Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Independent Diagnostic Laboratory Case Studies

Figure 9. Lung Cancer Diagnostic And Screening Report Years Considered

Figure 10. Global Lung Cancer Diagnostic And Screening Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Lung Cancer Diagnostic And Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Lung Cancer Diagnostic And Screening Market Share by Region: 2023 VS 2030

Figure 13. Global Lung Cancer Diagnostic And Screening Market Share by Players in 2023

Figure 14. Global Top Lung Cancer Diagnostic And Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic And Screening as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostic And Screening Revenue in 2023

Figure 16. North America Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Lung Cancer Diagnostic And Screening Market Share by Country (2019-2030)

Figure 18. United States Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Lung Cancer Diagnostic And Screening Market Share by Country (2019-2030)

Figure 22. Germany Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Lung Cancer Diagnostic And Screening Market Share by Region (2019-2030)

Figure 30. China Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Lung Cancer Diagnostic And Screening Market Share by Country (2019-2030)

Figure 38. Mexico Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Lung Cancer Diagnostic And Screening Market Share by Country (2019-2030)

Figure 42. Turkey Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Lung Cancer Diagnostic And Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Pfizer Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 45. F.Hoffmann-La Roche AG Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 46. Bristol-Myers Squibb Company Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 48. AstraZeneca Plc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 49. Abbott Laboratories Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 50. Medtronic Plc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 51. Danaher Corporation Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 52. Siemens Healthcare GmbH Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 53. FUJIFILM Corporation Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 54. KoninklijikePhilips N.V. Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 55. GE Healthcare Bio Sciences AB Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 56. Quest Diagnostics lIncorporated Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 57. Agilent Technologies lnc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 58. Qiagen Inc. Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 59. Myriad Genetic Laboratories Inc. Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 60. NeoGenomics Laboratories Inc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 61. Canon MedicalSystems Corporation Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 62. Eon Health Inc Revenue Growth Rate in Lung Cancer Diagnostic And Screening Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions